
Commentary|Podcasts|November 10, 2023
Pharmacy Focus: Psychedelic Pharmacy- Investigating Psilocybin-Assisted Therapy
Jordan Sloshower, MD, MSc, describes his experience working in several clinical trials investigating psilocybin-assisted therapy.
Advertisement
This month, we spoke with Jordan Sloshower, MD, MSc, about an upcoming course titled Critical Perspectives on Knowledge Production in Psychedelic Science at Chacruna Institute in which he will be addressing some issues regarding psilocybin-assisted therapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
5





















































































































































































































